lithium-chloride and Machado-Joseph-Disease

lithium-chloride has been researched along with Machado-Joseph-Disease* in 2 studies

Other Studies

2 other study(ies) available for lithium-chloride and Machado-Joseph-Disease

ArticleYear
Lithium chloride therapy fails to improve motor function in a transgenic mouse model of Machado-Joseph disease.
    Cerebellum (London, England), 2014, Volume: 13, Issue:6

    The accumulation of misfolded proteins in neurons, leading to the formation of cytoplasmic and nuclear aggregates, is a common theme in age-related neurodegenerative diseases, possibly due to disturbances of the proteostasis and insufficient activity of cellular protein clearance pathways. Lithium is a well-known autophagy inducer that exerts neuroprotective effects in different conditions and has been proposed as a promising therapeutic agent for several neurodegenerative diseases. We tested the efficacy of chronic lithium (10.4 mg/kg) treatment in a transgenic mouse model of Machado-Joseph disease, an inherited neurodegenerative disease, caused by an expansion of a polyglutamine tract within the protein ataxin-3. A battery of behavioral tests was used to assess disease progression. In spite of activating autophagy, as suggested by the increased levels of Beclin-1, Atg7, and LC3-II, and a reduction in the p62 protein levels, lithium administration showed no overall beneficial effects in this model concerning motor performance, showing a positive impact only in the reduction of tremors at 24 weeks of age. Our results do not support lithium chronic treatment as a promising strategy for the treatment of Machado-Joseph disease (MJD).

    Topics: Animals; Apoptosis Regulatory Proteins; Ataxin-3; Autophagy; Autophagy-Related Protein 7; Beclin-1; Brain; Disease Models, Animal; Disease Progression; Exploratory Behavior; Humans; Lithium Chloride; Machado-Joseph Disease; Male; Mice, Transgenic; Microtubule-Associated Proteins; Motor Activity; Nerve Tissue Proteins; Neuromuscular Agents; Nuclear Proteins; Postural Balance; Repressor Proteins; Treatment Outcome; Tremor; Weight Loss

2014
Normal prion protein in Drosophila enhances the toxicity of pathogenic polyglutamine proteins and alters susceptibility to oxidative and autophagy signaling modulators.
    Biochemical and biophysical research communications, 2011, Jan-14, Volume: 404, Issue:2

    To investigate the in vivo functions of normal prion protein (PrP) in Drosophila, we utilized characterized transgenic flies expressing ³(F)⁴-tagged mouse PrP (Mo-PrP³(F)⁴). The neurotoxicity of pathogenic Machado-Joseph Disease (MJD) glutamine (Q) 78 and 127Q proteins were enhanced by the co-expression of Mo-PrP³(F)⁴in the fly eyes, while the eyes of controls flies and flies expressing Mo-PrP³(F)⁴) alone or together with MJD-Q27 or 20Q proteins did not show any defect. Susceptibilities to H₂O₂, paraquat, and Dithiothreitol (DTT) were altered in Mo-PrP³(F)⁴ flies. In addition, Mo-PrP³(F)⁴ flies were significantly more susceptible to the perturbation of autophagy signaling by an autophagy inhibitor, 3-methyladenine (3-MA), and inducer, LiCl. Taken together, our data suggest that Mo-PrP³(F)⁴ may enhance the neurotoxicity of pathogenic Poly-Q proteins by perturbing oxidative and autophagy signaling.

    Topics: Adenine; Animals; Animals, Genetically Modified; Autophagy; Disease Models, Animal; Dithiothreitol; Drosophila melanogaster; Eye; Lithium Chloride; Machado-Joseph Disease; Mice; Models, Genetic; Neurons; Oxidative Stress; Paraquat; Peptides; Prions; Unfolded Protein Response; Water

2011